Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction.
Cantarovich
M
M
Royal Victoria Hospital, McGill University Health Center, Montréal, Québec, Canada.
Quantz
M
M
Elstein
E
E
Ergina
P
P
Magnan
C
C
de Varennes
B
B
D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D009202:Cardiomyopathies / Q000601:surgery; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008775:Methylprednisolone